Autologous Incubated Macrophages for Patients With Complete Spinal Cord Injuries
Public ClinicalTrials.gov record NCT00073853. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II Multicenter, Randomized-Controlled Study to Evaluate the Safety and Efficacy of Autologous Incubated Macrophages for the Treatment of Patients With Complete Spinal Cord Injuries
Study identification
- NCT ID
- NCT00073853
- Recruitment status
- Suspended
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Proneuron Biotechnologies
- Industry
- Enrollment
- 61 participants
Conditions and interventions
Conditions
Interventions
- Autologous Incubated Macrophages (cell therapy) Procedure
Procedure
Eligibility (public fields only)
- Age range
- 16 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2003
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Aug 27, 2009
Started 2003
United States locations
- U.S. sites
- 6
- U.S. states
- 5
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Craig Hospital | Englewood | Colorado | 80110 | — |
| Shepherd Center | Atlanta | Georgia | 30309 | — |
| UMDNJ | Newark | New Jersey | 07103 | — |
| Kessler Medical Rehabilitation Research and Education Corporation | West Orange | New Jersey | 07052 | — |
| Mount Sinai Spinal Cord Injury Model System | New York | New York | 10029 | — |
| Shriners Hospital for Children | Philadelphia | Pennsylvania | 19140 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00073853, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 27, 2009 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00073853 live on ClinicalTrials.gov.